Extendicare (EXE) Stock Forecast, Price & News

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Extendicare in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" EXE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EXE, but not buy additional shares or sell existing shares.
View EXE analyst ratings or view top-rated stocks.

3 Wall Street analysts have issued 1 year price targets for Extendicare's stock. Their EXE share price forecasts range from C$7.00 to C$8.00. On average, they predict the company's share price to reach C$7.50 in the next twelve months. This suggests a possible upside of 5.5% from the stock's current price.
View analysts price targets for EXE or view top-rated stocks among Wall Street analysts.

Extendicare's stock was trading at C$6.56 on January 1st, 2023. Since then, EXE stock has increased by 8.4% and is now trading at C$7.11.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our EXE earnings forecast.

Extendicare Inc. (TSE:EXE) released its quarterly earnings data on Thursday, March, 2nd. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by $0.13. The business had revenue of $310.39 million for the quarter, compared to analyst estimates of $309.50 million. Extendicare had a net margin of 6.21% and a trailing twelve-month return on equity of 3.01%.

Extendicare announced a monthly dividend on Thursday, May 4th. Shareholders of record on Wednesday, May 31st will be paid a dividend of 0.04 per share on Thursday, June 15th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 6.75%. The ex-dividend date of this dividend is Tuesday, May 30th.
Read our dividend analysis for EXE.

Extendicare (TSE:EXE) pays an annual dividend of C$0.48 per share and currently has a dividend yield of 6.62%. EXE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 960.00%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for EXE.

Based on aggregate information from My MarketBeat watchlists, some companies that other Extendicare investors own include Inter Pipeline (IPL), Pembina Pipeline (PPL), BCE (BCE), Chorus Aviation (CHR), Cenovus Energy (CVE), Medical Facilities (DR), Martinrea International (MRE), Air Canada (AC), AltaGas (ALA) and Emera (EMA).

Extendicare trades on the Toronto Stock Exchange (TSX) under the ticker symbol "EXE."

Shares of EXE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

One share of EXE stock can currently be purchased for approximately C$7.11.

Extendicare (TSE:EXE) has a market capitalization of C$600.01 million and generates C$1.24 billion in revenue each year. The company earns C$3.02 million in net income (profit) each year or C$0.05 on an earnings per share basis.

The company employs 23,000 workers across the globe.

The official website for the company is www.extendicare.com. The company can be reached via phone at 905-470-4000.